Art

J-GLOBAL ID：201202216240969343   Reference number：12A1681722

Anti-Atherogenic Effects of the Combination Therapy with Olmesartan and Azelnidipine in Diabetic Apolipoprotein E-Deficient Mice

糖尿病性アポリポ蛋白質E欠損マウスにおけるオルメサルタンとアゼルニジピン併用療法の抗アテローム形成効果

Author (6)： NODA Kazuki (Dep. of Cardiovascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  HOSOYA Maki (Dep. of Cardiovascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  NAKAJIMA Sota (Dep. of Cardiovascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  OHASHI Junko (Dep. of Cardiovascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  FUKUMOTO Yoshihiro (Dep. of Cardiovascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  SHIMOKAWA Hiroaki (Dep. of Cardiovascular Medicine, Tohoku Univ. Graduate School of Medicine)
Material： Tohoku Journal of Experimental Medicine  (Tohoku J Exp Med)
Volume： 228  Issue： 4  Page： 305-315 (J-STAGE)  Publication year： 2012 
JST Material Number： G0649A  ISSN： 0040-8727  CODEN： TJEMAO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： Mus musculus ,...
Semi thesaurus term： antiatherogenic effect

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1681722&from=J-GLOBAL&jstjournalNo=G0649A") }}

JST classification (1)： Basic research of vasoactive drugs and hypotensive drugs  (GW07040J)

Substance index (2)： Olmesartan ,  Azelnidipine

Reference (53)：

• Abe, M., Maruyama, N., Okada, K., Matsumoto, S., Matsumoto, K. & Soma, M. (2011) Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria. <i>Hypertens. Res</i>., <b>34</b>, 935-941.
• Bauer, P.M., Fulton, D., Boo, Y.C., Sorescu, G.P., Kemp, B.E., Jo, H. & Sessa, W.C. (2003) Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. <i>J. Biol. Chem</i>., <b>278</b>, 14841-14849.
• Charo, I.F. & Taubman, M.B. (2004) Chemokines in the pathogenesis of vascular disease. <i>Circ. Res</i>., <b>95</b>, 858-866.
• Dudzinski, D.M. & Michel, T. (2007) Life history of eNOS: partners and pathways. <i>Cardiovasc. Res</i>., <b>75</b>, 247-260.
• Fliser, D., Buchholz, K. & Haller, H. (2004) Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. <i>Circulation</i>, <b>110</b>, 1103-1107.

Terms in the title (8)： 糖尿病 ,  アポリポ蛋白質E ,  欠損 ,  マウス ,  オルメサルタン ,  アゼルニジピン ,  併用療法 ,  アテローム形成